Back to Search
HANIFAH DAVIS, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1003330952Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Population pharmacokinetics of golimumab, an anti-tumor necrosis factor-alpha human monoclonal antibody, in patients with psoriatic arthritis.
PMID 19617465·J Clin Pharmacol·2009
3-trial
Presenting features and early management of childhood intermittent exotropia in the UK: inception cohort study.
PMID 19605936·Br J Ophthalmol·2009
4-observational
Cardiometabolic risk and health care utilization and cost for Hispanic and non-Hispanic women.
PMID 19663619·Popul Health Manag·2009
8-other
Erlotinib for the treatment of relapsed non-small cell lung cancer.
PMID 19567213·Health Technol Assess·2009
8-other
Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma.
PMID 19567210·Health Technol Assess·2009
8-other
Risk-based strategy for the assessment of pharmacokinetic drug-drug interactions for therapeutic monoclonal antibodies.
PMID 19520183·Drug Discov Today·2009
6-review
Economic evaluation of an intensive home visiting programme for vulnerable families: a cost-effectiveness analysis of a public health intervention.
PMID 19497944·J Public Health (Oxf)·2009
4-observational
Validation of Bayesian kriging of arsenic, chromium, lead, and mercury surface soil concentrations based on internode sampling.
PMID 19603658·Environ Sci Technol·2009
8-other
Catecholamine levels in hypoxia-lnduced acute mountain sickness.
PMID 19378908·Aviat Space Environ Med·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 921 NE 13TH ST
OKLAHOMA CITY, OK 73104 - Phone
- (405) 456-4131
Quick Facts
- NPI
- 1003330952
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile